NO170896B - CLOTHING ELEMENT AND PROCEDURE FOR MANUFACTURING SUCH ITEMS - Google Patents
CLOTHING ELEMENT AND PROCEDURE FOR MANUFACTURING SUCH ITEMS Download PDFInfo
- Publication number
- NO170896B NO170896B NO891520A NO891520A NO170896B NO 170896 B NO170896 B NO 170896B NO 891520 A NO891520 A NO 891520A NO 891520 A NO891520 A NO 891520A NO 170896 B NO170896 B NO 170896B
- Authority
- NO
- Norway
- Prior art keywords
- demethyl
- epipodophyllotoxin
- glucoside
- carbobenzoxy
- acetyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 238000000034 method Methods 0.000 title claims description 9
- 229940057499 anhydrous zinc acetate Drugs 0.000 claims description 10
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 238000006136 alcoholysis reaction Methods 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 61
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 229960001237 podophyllotoxin Drugs 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006345 epimerization reaction Methods 0.000 description 3
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Substances FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- -1 demethyl podophyllotoxin Chemical compound 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 201000006512 mast cell neoplasm Diseases 0.000 description 2
- 238000006140 methanolysis reaction Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PDWQYOPXBHPSCA-UHFFFAOYSA-N 1,2-dichloroethane;oxolane Chemical compound ClCCCl.C1CCOC1 PDWQYOPXBHPSCA-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- OAABHEHWRQAHEJ-UHFFFAOYSA-N butan-1-ol;chloroform Chemical compound ClC(Cl)Cl.CCCCO OAABHEHWRQAHEJ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 208000006971 mastocytoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Description
Fremgangsmåte for fremstilling av 4'-demetyl-epipodofyllotoksin-S-D-glukosid med terapeutisk Process for the production of 4'-demethyl-epipodophyllotoxin-S-D-glucoside with therapeutic
virkning. effect.
Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av <l>+<i_>demetyl-epipodofyllotoksin-|3-D-glukosid med terapeutisk virkning og med formel (I) The present invention relates to a method for the production of <l>+<i_>demethyl-epipodophyllotoxin-|3-D-glucoside with therapeutic effect and with formula (I)
og særegne ved framgangsmåten i henhold til oppfinnelsen..er at i. tetra-O-acétyl-^' -kdrboDénzoksy-^' -demetyl-Gpipodofyllo-tok .. n-p-D-glukosid med formel (II) enten avspaltes forst .karbobenzoksygruppen hydroge.nolytisk og det således erholdte tetra-O-acetyl-^'-demetyl-epipodofyllotoksin-(3-D-glukosid med formel (III) ....... and distinctive in the method according to the invention..is that i. tetra-O-acetyl-^'-kdrboDénzoxy-^'-demethyl-Gpipodophyllo-tok .. n-p-D-glucoside with formula (II) is either cleaved off first .the carbobenzoxy group hydroge. nolytically and the thus obtained tetra-O-acetyl-^'-demethyl-epipodophyllotoxin-(3-D-glucoside of formula (III) .......
underkastes ' en alkoholyse i nærvær av vannfritt sinkacetat, eller subjected ' to an alcoholysis in the presence of anhydrous zinc acetate, or
acetylgruppene avspaltes forst alkoholytlsk i nærvær av vannfritt sinkacetat eller en blanding av vannfritt sinkacetat og natriumacetat^og karbobenzoksygruppen fjernes deretter hydrogenolytisk. the acetyl groups are first cleaved alcoholically in the presence of anhydrous zinc acetate or a mixture of anhydrous zinc acetate and sodium acetate^ and the carbobenzoxy group is then removed hydrogenolytically.
De enkelte fremgangsmåtetrekk gjennomføres på folgende måte: The individual procedural steps are carried out in the following way:
UTyTlrcge nolyse UTyTlrcge nolysis
Hydrogonolysen foretas etter i og for seg kjente metoder. !lnr\/e:i hydreres hensiktsmessig uten overtrykk og ved 20 til maksimali'. Hydrogonolysis is carried out according to methods known per se. !lnr\/e:i is appropriately hydrated without excess pressure and at 20 to maximum.
k0' C i liser vær av palladiumkatalysatorer, f. eks. palladium på kull eller py bariumsulfat. Som løsningsmiddel kommer fortrinnsvis alkoholer, som f.eks. metanol eller etanol, under tilsetning av 0,5 til 5 volum- iseddik og 10 til 50 volum- aceton på tale. Katalysatormengden utgjor 1 til 5 vekt%, regnet på anvendt substans. k0' C i liser weather of palladium catalysts, e.g. palladium on charcoal or py barium sulphate. Alcohols are preferably used as solvents, such as e.g. methanol or ethanol, with the addition of 0.5 to 5 volumes of glacial acetic acid and 10 to 50 volumes of acetone. The amount of catalyst is 1 to 5% by weight, calculated on the substance used.
Alkoholyse Alcohololysis
Det var ikke å vente at man fra tetra-O-acetyl-^-'-karbobenzoksy--demetyl-epipodofyllotoksin-p-D-glukosid henhv. tetra-O-acetyl-h'-demetyl-epipodofyllotoksin-p-D-glukosid skulle kunne avspalte acetylgruppen hydrolytisk under vanlige basiske og sure betingelser, for på denne måte å komme frem til det tilsvarende fri glukosid. Som kjent undergår lignaglukosider epimerisering med baser, mens innvirkning av syrer kan fore til spalting under avspalting av sukkerresten. It was not to be expected that from tetra-O-acetyl-^-'-carbobenzoxy--demethyl-epipodophyllotoxin-p-D-glucoside or tetra-O-acetyl-h'-demethyl-epipodophyllotoxin-p-D-glucoside should be able to split off the acetyl group hydrolytically under normal basic and acidic conditions, in order to arrive at the corresponding free glucoside in this way. As is known, lignanglucosides undergo epimerization with bases, while the influence of acids can lead to cleavage during removal of the sugar residue.
Det ble nå overraskende funnet at man fra tetra-O-acetyl-V-karbobenzoksy-V -demetyl-epipodofyllotoksin-f3-D-glukosid henhv. It was now surprisingly found that from tetra-O-acetyl-V-carbobenzoxy-V-demethyl-epipodophyllotoxin-f3-D-glucoside or
fra tetra-O-acetyl-^f<1->demetyl-epipodofyllotoksin-p-D-glukosid kunne fjerne acetylrestene uten samtidig epimerisering av aglykonet ved C-3-atomet og uten avspalting av den samlede sukkerrest, idet disse forbindelser underkastes en alkoholyse, fortrinnsvis med metanol, i nærvær av vannfritt sinkacetat. from tetra-O-acetyl-^f<1->demethyl-epipodophyllotoxin-p-D-glucoside could remove the acetyl residues without simultaneous epimerization of the aglycon at the C-3 atom and without cleavage of the total sugar residue, as these compounds are subjected to an alcoholysis, preferably with methanol, in the presence of anhydrous zinc acetate.
Metanolysen gjenncnfores i vannfri metanol ved tilbakelopstemperatir. Katalysatormengden ligger på ca. 20-50 vekt$ regnet på anvendt tetra-0-acetyl-^1 -derne tyl-epipodofyllotoksin-B-D-glukosid. Reaksjonstiden utgjor mellom 15 og 30 timer. Ved metanolyse av tetra-O-acetyl-^f' -dem±yl-epipodofyllotoksin-|3-D-glukosid dannes med sinkacetat som katalysator i lopet av reaksjonen en felling. The methanolysis is repeated in anhydrous methanol at reflux temperature. The amount of catalyst is approx. 20-50 weight$ calculated on the tetra-O-acetyl-^1 -deren tyl-epipodophyllotoxin-B-D-glucoside used. The reaction time is between 15 and 30 hours. During the methanolysis of tetra-O-acetyl-^f'-dem±yl-epipodophyllotoxin-|3-D-glucoside, a precipitate is formed with zinc acetate as catalyst in the course of the reaction.
For opparbeidelsen bringes dette bunnfall til losning ved tilsetning av eddiksyre og forsiktig oppvarming. For processing, this precipitate is dissolved by the addition of acetic acid and gentle heating.
Etter avdamping av losningsmidle/t loses resten i en blanding av kloroform/butanol og sinksallme fjernes ved utrysting med vann. After evaporation of the solvent/t, the residue is dissolved in a mixture of chloroform/butanol and the zinc salt is removed by shaking with water.
Fra den organiske fase isoleres etter inndamping det rå V-demetyl-epipodofyllotoksin-p-D-glukosid som renses på kjent måte, f.eks. ved kromatografering og/eller krystallisering. From the organic phase, the crude V-demethyl-epipodophyllotoxin-β-D-glucoside is isolated after evaporation, which is purified in a known manner, e.g. by chromatography and/or crystallization.
Som ovenfor angitt kan man imidlertid ved avspalting av beskyttelsesgruppene også gå frem i omvendt rekkefolge, idet forst tetra-O-acetyl-^f1 -karbobenzoksy-1*' -dernetyl-epipodofyllotoksin-p-D-glukosid i nærvær av vannfritt sinkacetat og eventuell tilsetning av vannfritt natriumacetat i metanol kokes så lenge under tilbakelop at avspaltingen av acetjlgruppen er avsluttet, hvorved samtidig også karbobenzoksygruppen divis avspaltes. Fra den således dannede blanding av reaksjonskomponentene kan det hittil ukjente V-karbobenzoky-V-demetyl-epipodofyllotoksin-B-D-glukosid med formel (IV) As indicated above, however, when removing the protective groups, one can also proceed in the reverse order, firstly tetra-O-acetyl-β1-carbobenzoxy-1*'-dernetyl-epipodophyllotoxin-β-D-glucoside in the presence of anhydrous zinc acetate and possible addition of Anhydrous sodium acetate in methanol is boiled under reflux for so long that the cleavage of the acetyl group is completed, whereby at the same time the carbobenzoxy group is also split off in parts. From the thus formed mixture of the reaction components, the hitherto unknown V-carbobenzoky-V-demethyl-epipodophyllotoxin-B-D-glucoside of formula (IV)
isoleres, som videre ved hydrogenolyse av karbobenzoksygruppen overfores i -dernetyl-epipodofyllotoksin-S-D-glukosid. is isolated, which is further converted by hydrogenolysis of the carbobenzoxy group into -dernetyl-epipodophyllotoxin-S-D-glucoside.
Det for fremstilling av V-demetyl-epipodofyllotoksin-B-D-glukosid tjenende utgangsstoff tetra-O-acetyl-M-' -karbobenzoksy-V -demetyl-epipodofyllotoksin-B-D-glukosid fremstilles etter folgende metode: The starting material used for the production of V-demethyl-epipodophyllotoxin-B-D-glucoside tetra-O-acetyl-M-'-carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside is prepared according to the following method:
Det ble funnet at omsetningen av 2,3,^,6-tetra-O-acetyl-D-glukose It was found that the turnover of 2,3,^,6-tetra-O-acetyl-D-glucose
i form av dets rene B-anomer såvel med K<*->karbobenzpksy-V-demetyl-podofyllotoksin med formel (V) in the form of its pure B-anomer as well as with K<*->carbobenzpxy-V-demethyl podophyllotoxin of formula (V)
såvel som med -karbobenzoksy-V-dernetyl-epipodofyllotoksin med formel (VI) as well as with -carbobenzoxy-V-dernetyl-epipodophyllotoxin of formula (VI)
dvs. uavhengig av stereokjemien av OH-gruppen ved C-1 karbonatomet i aglykonet, i nærvær av bortrifluorid-etyleterat ved en temperatur på under 0°C i et under reaksjonsbetingelsene inert losningsmidde1 forer til tetra-O-acetyl-V-karbobenzoksy-^1 - demetyl-epipodofyllotoksin-p-D-glukosid i hoyt utbytte. i.e. regardless of the stereochemistry of the OH group at the C-1 carbon atom in the aglycone, in the presence of boron trifluoride ethyl etherate at a temperature below 0°C in a solvent inert under the reaction conditions1 leads to tetra-O-acetyl-V-carbobenzoxy-^ 1 - demethyl-epipodophyllotoxin-β-D-glucoside in high yield.
De for fremstillingen av tetra-O-acetyl-V-karbobenzoksy-V-dernetyl-epipodofyllotoksin-B-D-glukosid tjenende utgangsstoffer h<1->karbobenzoksy-V-demetyl-podofylltotoksin hechv. V-karbobenzoksy-V-demetyl-epipodofyllotoksin fremstilles etter folgende fremgangsmåte: The starting materials used for the production of tetra-O-acetyl-V-carbobenzoxy-V-dernetyl-epipodophyllotoxin-B-D-glucoside h<1->carbobenzoxy-V-demethyl-podophylltotoxin hechv. V-carbobenzoxy-V-demethyl-epipodophyllotoxin is produced according to the following procedure:
k1-demetyl-podofylldtoksin' med formel (VII) k1-demethyl podophyll toxin' of formula (VII)
henhv. V-demetyl-epipodofylitoksin med formel (VIII) respectively V-demethyl-epipodophyllitoxin of formula (VIII)
omsettes i et vannfritt, under reaksjonsbetingelsene inert organisk løsningsmiddel ved temperaturer mellom -20 og -5°C i nærvær av en tertiær organisk base med klormaursyrebenzylester til V-karbobenzoksy-V-demetyl-epipodofyllotoksin henhv. is reacted in an anhydrous, under the reaction conditions inert organic solvent at temperatures between -20 and -5°C in the presence of a tertiary organic base with chloroformic acid benzyl ester to V-carbobenzoxy-V-demethyl-epipodophyllotoxin resp.
V-karbobenzoks<y>-^-'-denretyl-podofyllotoksin. V-carbobenzox<y>-^-'-denretyl podophyllotoxin.
Det som utgangsmaterial anvendte V-demetyl-epipodofyllotoksin kan The V-demethyl-epipodophyllotoxin used as starting material can
erholdes ved epimerisering av h<*->demetyl-podofyllotoksin is obtained by epimerization of h<*->demethyl podophyllotoxin
(se eks. 1). Fremstillingen av k'-karbobenzoksy-V-demetyl-podofyllotoksin skjer på kjent måte, utgående fra -demetyl-podofyllotoksin, idet det pr. mol V-demetyl-podofyllotoksin anvendes 1,0 - 1,6 mol karbobenzoksyklorid. (see ex. 1). The production of k'-carbobenzoxy-V-demethyl-podophyllotoxin takes place in a known manner, starting from -demethyl-podophyllotoxin, as per mol V-demethyl-podophyllotoxin 1.0 - 1.6 mol carbobenzoxychloride is used.
V-demetyl-epipodofyllotoksin-B-D-glukosid utover in vitro en hoy cytostatisk virkning på mastocytomceller og fibroblastkulturer. Videre utmerker det seg ved en sterk virksomhet mot eksperimentelle tumorer, særlig cverfor muselaikemi L-1210. h<1->demetyl-epipodofyllotoksin-B-D-glukosid kan anvendes terapeutisk for å bekjempe patalogiske prosesser som har forbindelse med celleformering, f.eks. maligne neoplasmer. Doseringen av -demetyl-epipodofyllotoksin-6-D-glukosid varieres mellom omtrent 1 og 50 mg pr. dag. V-demethyl-epipodophyllotoxin-B-D-glucoside in addition to a high cytostatic effect on mastocytoma cells and fibroblast cultures in vitro. Furthermore, it is distinguished by its strong activity against experimental tumors, especially against mouse leukemia L-1210. h<1->demethyl-epipodophyllotoxin-B-D-glucoside can be used therapeutically to combat pathological processes related to cell proliferation, e.g. malignant neoplasms. The dosage of -demethyl-epipodophyllotoxin-6-D-glucoside is varied between approximately 1 and 50 mg per day.
Det fremstilte V-demetyl-epipodofyllotoksin-8-D-glukosid utmerker seg som nevnt ved interessante terapeutiske egenskaper. Ved en spesifikk sammenligning av h'-demetyl-epipodofyllotoksin-B-D-glukosid med det i det tyske patentskrift nr. 959.192 og det norske patentskrift nr. 93«077 tidligere kjente podofyllotoksin-8-D-glukosid viser det seg at den i henhold til foreliggende fremgangsmåte fremstillbare forbindelse har en vesentlig mer utpreget selektiv hemmende virkning på delingsprosessen i cellekjernene. Den nevnte forbindelse ble pi5vet in vi tro på kulturen av mastcelletumor P 81 5 i mus. Med DE^-q betegnes i den folgende tabell den konsentrasjon som hemmer celleveksten for mastcellene med 50$. As mentioned, the produced V-demethyl-epipodophyllotoxin-8-D-glucoside is distinguished by interesting therapeutic properties. In a specific comparison of h'-demethyl-epipodophyllotoxin-B-D-glucoside with the previously known podophyllotoxin-8-D-glucoside in German patent document no. 959,192 and Norwegian patent document no. 93,077, it turns out that according to the present process-producible compound has a significantly more pronounced selective inhibitory effect on the division process in the cell nuclei. The said compound was pi5vet in vi tro the culture of mast cell tumor P 81 5 in mice. In the following table, DE^-q denotes the concentration which inhibits cell growth for the mast cells by 50$.
V-demetyl-epipodofyllotoksin-8-D-glukosid kan finne anvendelse V-demethyl-epipodophyllotoxin-8-D-glucoside may find application
som legemiddel i seg selv eller i tilsvarende legemiddelformer for oral, enteral eller parenteral administrering. For fremstilling av egnede legemiddelformer forarbeides forbindelsen med organiske eller uorganiske, farmakologisk indifferente hjelpestoffer. 1 de etterfølgende eksempler er alle temperaturangivelser i °C. Smelte- henhv.spaltingspunktene er bestemt på Kofler-blokk. as a drug in itself or in equivalent drug forms for oral, enteral or parenteral administration. For the production of suitable medicinal forms, the compound is processed with organic or inorganic, pharmacologically indifferent excipients. 1 the following examples are all temperature indications in °C. The melting or fission points are determined on the Kofler block.
Eks. 1 - 4 illustrerer fremstilling av utgangsmaterialer. Ex. 1 - 4 illustrate the production of starting materials.
EKSEMPEL 1: V- demetyl- epipodofyllotoksin EXAMPLE 1: V-demethyl-epipodophyllotoxin
2 g h<1->demetyl-podofyllotoksin loses i 25 ml aceton og 15 ml vann og oppvarmes etter tilsetning av 5 ml konsentrert saltstyre i 2 timer under tilbakelbp. Deretter nøytraliseres syren med fast bariumkarbonat, det filtreres og filtratet befris for aceton i vakuum ved <1>+0°C. Det utfelte material opptas i kloroform pluss 5$ aceton, løsningen torres over natriumsulfat og inndampes i vakuum. Resten kromatograferes på silikagel med kloroform pluss 1$ metanol, hvorved det feist erholdes små mengder forurensninger og deretter rent V-demetyl-epipodofyllotoksin og til slutt uomsatt utgangsmaterial. Krystallisering av de rene fraksjoner av V-demetyl-epipodofyllotoksin skjer fra kloroform og metanol. 2 g of h<1->demethyl-podophyllotoxin are dissolved in 25 ml of acetone and 15 ml of water and heated after adding 5 ml of concentrated sodium chloride for 2 hours under reflux. The acid is then neutralized with solid barium carbonate, it is filtered and the filtrate is freed of acetone in a vacuum at <1>+0°C. The precipitated material is taken up in chloroform plus 5% acetone, the solution is dried over sodium sulphate and evaporated in vacuo. The residue is chromatographed on silica gel with chloroform plus 1% methanol, whereby small amounts of impurities and then pure V-demethyl-epipodophyllotoxin and finally unreacted starting material are obtained. Crystallization of the pure fractions of V-demethyl-epipodophyllotoxin takes place from chloroform and methanol.
Smp. 228-230°C, C<tJ^ ° = -69,8° (c = 0,630 i kloroform). Temp. 228-230°C, C<tJ^ ° = -69.8° (c = 0.630 in chloroform).
EKSEMPEL 2: V- karbobenzoksy- V- demetyl- epipodofyllotoksin EXAMPLE 2: V- carbobenzoxy- V- demethyl- epipodophyllotoxin
60 g stovfint pulverisert V-demetyl-epipodofyllotoksin suspenderes i 1000 ml vannfritt etylenklorid og etter tilsetning av 19 nil abs. pyridin avkjbles til -10°C. Under roring og utelukkelse av fuktighet tildryppes ved -10°C i lopet av 2-jr time en losning av 3^ g klormaursyrebenzylester i 100 ml etylenklorid og deretter omsettes en ytterligere -g:t. Deretter vaskes reaksjons-losningen med vann, den organiske fase torres over natriumsulfat, inndampes i vakuum og resten toires i hoyvakuum ved 70-80°C. Krystallisering av råproduktet fra aceton/eter og deretter to ganger fra metanol gir V-karbobenzoksy-V-demetyl-epipodofyllotoksin med dobbeltsmeltepunkt 117-119/202-205°C. Ved torring i hoyvakuum fast ved 95-110°C og deretter ved 130°c eller krystallisering fra aceton/eter erholdes den lbsningsmiddelfrie form med smeltepunkt 201-20<>>+OC, Z«7D21 = -^3,9° (c = 0,535) i CHCl^. 60 g of finely powdered V-demethyl-epipodophyllotoxin are suspended in 1000 ml of anhydrous ethylene chloride and after the addition of 19 nil abs. pyridine is cooled to -10°C. While stirring and excluding moisture, a solution of 3^ g of benzyl chloroformic acid in 100 ml of ethylene chloride is added dropwise at -10°C over the course of 2 hours and then a further -g:t is reacted. The reaction solution is then washed with water, the organic phase is dried over sodium sulphate, evaporated in a vacuum and the residue dried in a high vacuum at 70-80°C. Crystallization of the crude product from acetone/ether and then twice from methanol gives V-carbobenzoxy-V-demethyl-epipodophyllotoxin with double melting point 117-119/202-205°C. By drying in a high vacuum solid at 95-110°C and then at 130°C or crystallization from acetone/ether, the solvent-free form is obtained with melting point 201-20<>>+OC, Z«7D21 = -^3.9° (c = 0.535) in CHCl^.
EKSEMPEL 3: V- karbobenzoksy- V- demetyl- podofyllotoksin EXAMPLE 3: V-carbobenzoxy-V-demethylpodophyllotoxin
1 5j0 g hx -demetyl-podofyllotoksin loses i <4>-50 ml varm abs. etylenklorid-tetrahydrofuranblanding 1:1, tilsettes 6,0 ml abs. pyridin og avkjoles til -10°C. Under roring og kjoling tildryppes nå i lopet av 1-g- time 8 ml klormaursyrebenzylester lost i 55 nil etylenklorid, og deretter rores i 1 time ved -5 til -10°C. Dissolve 1 5j0 g of hx -demethyl-podophyllotoxin in <4>-50 ml of warm abs. ethylene chloride-tetrahydrofuran mixture 1:1, add 6.0 ml abs. pyridine and cooled to -10°C. While stirring and cooling, 8 ml of chloroformic acid benzyl ester dissolved in 55 nil of ethylene chloride are now added dropwise in the course of 1 g per hour, and then stirred for 1 hour at -5 to -10°C.
Deretter inndampes ved h0 C badtemperatur i vakuum til et volum It is then evaporated at h0 C bath temperature in a vacuum to a volume
på 200 ml, det fortynnes med 250 ml etylenklorid og losningen vaskes en gang med 100 ml 1N saltsyre, deretter noytralt med vann. Etter torring over natriumsulfat inndampes i vakuum og resten kromatograferes på den 20-dobbelte mengde silikagel. Kloroform med \% metanol eluerer forst små mengder biprodukter, deretter rent h<*->karbobenzoksy-V-demetyl-podofyllotoksin. Etter krystallisering fra metanol smelter forbindelsen med 113-H<1>+<0>C. Æs7D<21>= -88,3° (kloroform). of 200 ml, it is diluted with 250 ml of ethylene chloride and the solution is washed once with 100 ml of 1N hydrochloric acid, then neutralized with water. After drying over sodium sulphate, it is evaporated in vacuo and the residue is chromatographed on the 20-fold amount of silica gel. Chloroform with \% methanol first elutes small amounts of by-products, then pure h<*->carbobenzoxy-V-demethyl-podophyllotoxin. After crystallization from methanol, the compound melts with 113-H<1>+<0>C. Δs7D<21>= -88.3° (chloroform).
EKSEMPEL <l>+: tetra- O- acetyl- V - karbobenzoksy- V - demetyl-epipodofyllotoksin- B- D- glukosid EXAMPLE <l>+: tetra- O- acetyl- V - carbobenzoxy- V - demethyl-epipodophyllotoxin- B- D- glucoside
10,7 g V-karbobenzoksy-V-demetyl-podofyllotoksin loses under oppvarming i 30 ml etylenklorid, losningen avkjoles til 15°C og det tilsettes 1^,0 g 2,3,^,6-tetra-O-acetyl-B-D-glukose. Etter 5 min. roring avkjoles under utelukkelse av fuktighet til 10.7 g of V-carbobenzoxy-V-demethyl-podophyllotoxin are dissolved while heating in 30 ml of ethylene chloride, the solution is cooled to 15°C and 1^.0 g of 2,3,^,6-tetra-O-acetyl-B-D is added -glucose. After 5 min. rowing is cooled to the exclusion of moisture
-15°C>og i lopet av 5 min. tildryppes 7 ml til -10°C forhånds-avkjolt bortrifluorid-etyleterat ( h8% BF-.). Deretter rores i 1 time ved -15 C, og så tildryppes en losniilg av 7 ml abs. pyridin i 20 ml etylenklorid. Etter fortynning med 100 ml kloroform vaskes 5 ganger med hver gang 50 ml vann. Den organiske fase torres over natriumsulfat, inndampes i vakuum og resten torres ved 60°C i vakuum. Det erholdte skum loses i 50 ml varm etanol. Det avkjoles til ca. 50°C, tilsettes 150 ml koldt vann og rores så lenge til at det til å begynne med klumpete og seige bunnfall var omdannet til et sandaktig pulver. Produktet filtreres, ettervaskes med ^0 ml 25% etanol og torres i vakuum ved 60°C. Deretter loses preparatet i 200 ml varm metanol, filtreres klart, filtratet inndampes i vakuum og resten torres i hoyvakuum ved 80°C til konstant vekt. Det på denne måte erholdte tetra-O-acetyl-V-karbobenzoksy-V-demetyl-epipodofyllotoksin-B-D-glukosid smelter ved 167-169°C, fqj^ 20 <=><->^6,6° (CHC13). -15°C>and within 5 min. 7 ml to -10°C pre-cooled boron trifluoride ethyl etherate (h8% BF-.) is added dropwise. It is then stirred for 1 hour at -15 C, and then a solution of 7 ml abs is added drop by drop. pyridine in 20 ml of ethylene chloride. After dilution with 100 ml of chloroform, wash 5 times with 50 ml of water each time. The organic phase is dried over sodium sulphate, evaporated in a vacuum and the residue is dried at 60°C in a vacuum. The resulting foam is dissolved in 50 ml of hot ethanol. It is cooled to approx. 50°C, 150 ml of cold water is added and stirred until the initially lumpy and tough sediment has been transformed into a sandy powder. The product is filtered, washed with ^0 ml of 25% ethanol and dried in vacuum at 60°C. The preparation is then dissolved in 200 ml of hot methanol, filtered clearly, the filtrate is evaporated in a vacuum and the residue is dried in a high vacuum at 80°C to constant weight. The tetra-O-acetyl-V-carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside thus obtained melts at 167-169°C, fqj^ 20 <=><->^6.6° (CHC13).
EKSEMPEL 5: tetra- O- acetyl- V - detiEbyl- epipodofyllotoksin- g- D- glukosid EXAMPLE 5: tetra- O- acetyl- V - detiEbyl- epipodophyllotoxin- g- D- glucoside
For avspalting av karbobenzoksyresten fra tetra-O-acetyl-^'-karbobenzoksy-V-demetyl-epipodofyllotoksin-B-D-glukosid loses 13A g av denne forbindelse i 100 ml aceton/etanol (1:2), tilsettes 0,5 ml iseddik og 2 g palladium/kull (med 10$ Pd) og det hydreres ved 20°C. Deretter frafiltreres katalysatoren, denne ettervaskes med varm aceton-metanolblanding og filtratet inndampes i vakuum. Resten overhelles med 100 ml kokende varm etanol, bringes til å krystallisere og krystallene torres etter avsuging og vasking med metanol i vakuum. Rent tetra-0-acetyl-^-<1->demetyl-epipodofyllotoksin-B-D-glukosid krystalliserer i fine nåler med smeltepunkt 225-227°C ^7D<21><=> - 6h, k° (c = 1,02»f) i kloroform. To cleave off the carbobenzoxy residue from tetra-O-acetyl-^'-carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside, dissolve 13A g of this compound in 100 ml of acetone/ethanol (1:2), add 0.5 ml of glacial acetic acid and 2 g palladium/charcoal (with 10$ Pd) and it is hydrated at 20°C. The catalyst is then filtered off, this is washed with a hot acetone-methanol mixture and the filtrate is evaporated in a vacuum. The residue is poured over with 100 ml of boiling hot ethanol, allowed to crystallize and the crystals are dried after suction and washing with methanol in a vacuum. Pure tetra-0-acetyl-^-<1->demethyl-epipodophyllotoxin-B-D-glucoside crystallizes in fine needles with melting point 225-227°C ^7D<21><=> - 6h, k° (c = 1.02 »f) in chloroform.
EKSEMPEL 6: *+'- dernetyl- epipodofyllotoksin- B- D- glukosid EXAMPLE 6: *+'- dernethyl- epipodophyllotoxin- B- D- glucoside
25 g rent tetra-O-acetyl-V-karbobenzoksy-^<1->demetyl-epipodofyllotoksin-B-D-glukosid, 3,6 g vannfritt sinkacetat og 1 ,*f5 g vannfritt natriumacetat oppvarmes i 1 50 ml metanol under tilbakelop og roring. Etter 2 og h timer avdestilleres hver gang 12,5 ml metanol. Deretter tilsettes etter hver 2 timer 12,5 ml metanol og avdestilleres på nytt. Etter ialt 18 timer er avspaltingen av acetylgruppen avsluttet og det foreligger en blanding av ca. 60% k<1->karbobenzoksy-V-demetyl-epipodofyllotoksin-B-D-glukosid og ca. h0% h<*->demetyl-epipodofyllotoksin-8-D-glukosid. 25 g of pure tetra-O-acetyl-V-carbobenzoxy-^<1->demethyl-epipodophyllotoxin-B-D-glucoside, 3.6 g of anhydrous zinc acetate and 1.*f5 g of anhydrous sodium acetate are heated in 1 50 ml of methanol under reflux and stirring . After 2 and h hours, 12.5 ml of methanol are distilled off each time. Then, after every 2 hours, 12.5 ml of methanol are added and distilled again. After a total of 18 hours, the cleavage of the acetyl group is complete and there is a mixture of approx. 60% k<1->carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside and approx. h0% h<*->demethyl-epipodophyllotoxin-8-D-glucoside.
Omsetningen skjer i tynnskiktkromatogram på silikagelplater med stromningsmidlet vannmettet isopropylaceta^metanol (<*>f:1). Fremkalling ved dusjing med en 0, 2% losning av Ce (IV)-sulfat i The reaction takes place in a thin-layer chromatogram on silica gel plates with the eluent, water-saturated isopropylaceta-methanol (<*>f:1). Development by showering with a 0.2% solution of Ce (IV)-sulphate i
50% svovelsyre og oppvarming til 110-130°C. 50% sulfuric acid and heating to 110-130°C.
For opparbeidingen tilsettes 5 ml iseddik, det inndampes i vakuum ved 50 C badtemperatur og torres i 15 minutter i hoyvakkum ved 50°C. Resten opptas i 250 ml kloroform/sopropanol (*f:1) og 25 ml vann, den vandige fase fraskilles og den organiske fase vaskes ytterligere med 25 ml vann. De to vaskevann ekstraheres med 50 ml kloroform/.sopro-panol og de forente organiske faser inndampes etter tbrring over natriumsulfat i vakuum. Resten destilleres 3 ganger med hver gang 30 ml aceton i vakuum og torres deretter i to timer i hoyvakuum ved 75°C. For the preparation, 5 ml of glacial acetic acid is added, it is evaporated in a vacuum at 50°C bath temperature and dried for 15 minutes in a high vacuum tank at 50°C. The residue is taken up in 250 ml of chloroform/isopropanol (*f:1) and 25 ml of water, the aqueous phase is separated and the organic phase is further washed with 25 ml of water. The two washing waters are extracted with 50 ml of chloroform/isopropanol and the combined organic phases are evaporated after drying over sodium sulphate in vacuum. The residue is distilled 3 times with each time 30 ml of acetone in vacuum and then dried for two hours in high vacuum at 75°C.
Fra blandingen av V-karbobenzoksy-V-demetyl-epipodofyllotoksin-B-D-glukosid og k'-demetyl-epipodofyllotoksin-8-D-glukosid kan det ved krystallisering fra metanol fremstilles V-karbobenzoksy-V-demetyl-epipodofyllotoksin-B-D-glukosid i ikke helt ren form. Kromatografering på den 100-dobbelte mengde silikagel gir ved eluering med isopropylacetalzmetanol (9:1), vannmettet, rent V -karbobenzoksy-M-1 -demetyl-epipodofyllotoksin-B-D-glukosid, som smelter ved 155-156°C etter krystallisering fra aceton. From the mixture of V-carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside and k'-demethyl-epipodophyllotoxin-8-D-glucoside, V-carbobenzoxy-V-demethyl-epipodophyllotoxin-B-D-glucoside can be prepared by crystallization from methanol in not quite pure form. Chromatography on the 100-fold amount of silica gel gives, eluting with isopropylacetalzmethanol (9:1), water-saturated, pure V -carbobenzoxy-M-1-demethyl-epipodophyllotoxin-B-D-glucoside, which melts at 155-156°C after crystallization from acetone .
/"ci7D21 = -92,0°C (c = 1,00) i kloroform. /"ci7D21 = -92.0°C (c = 1.00) in chloroform.
For avspaltingen av karbobenzoksygruppen loses blandingen av V-karbobenzoksy-V'-demetyl-epipodofylldtoksin-B-D-glukosid og For the cleavage of the carbobenzoxy group, the mixture of V-carbobenzoxy-V'-demethyl-epipodophyll toxin-B-D-glucoside and
V-demetyl-epipodofyllotoksin-B-D-glukosid i 200 ml aceton, losningen tilsettes til en suspensjon av 3 g palladiumk\ill (10$ Pd) i 50 ml vann og det hydreres til avsluttet avspalting av beskyttelsesgruppen (1,5 time). Kontroll av reaksjonen ved tynnskiktkromatogram som ovenfor. Deretter frafUtreres katalysatorenj denne ettervaskes med 100 ml aceton^ann (Vi) og filtratet inndampes i vakuum til et volum på ca. M-0-V5 ml, idet allerede V-demetyl-epipodofyllotoksin-B-D-glukosid begynner å utkrystallisere. For fullstendig krystallisering hensettes ennå 20 min. i isbad, de utfelte krystaller avsuges, det vaskes med 25 ml vann og torres i hoyvakuum ved 70°C. Krystallisering fra metanol gir rent V-demetyl-epipodofyllotoksin-8-D-glukosid med et smeltepunkt på 225-227°C, /"«7D<21> = -88,6° (c = 1,05) i metanol. En annen modifikasjon har smeltepunkt 262-26Lt-°C. V-demethyl-epipodophyllotoxin-B-D-glucoside in 200 ml of acetone, the solution is added to a suspension of 3 g of palladium metal (10$ Pd) in 50 ml of water and it is hydrated until the removal of the protecting group is complete (1.5 hours). Control of the reaction by thin-layer chromatogram as above. The catalyst is then filtered off, this is washed with 100 ml of acetone (Vi) and the filtrate is evaporated in vacuum to a volume of approx. M-0-V5 ml, as V-demethyl-epipodophyllotoxin-B-D-glucoside already begins to crystallize. Allow another 20 min for complete crystallization. in an ice bath, the precipitated crystals are filtered off, washed with 25 ml of water and dried in high vacuum at 70°C. Crystallization from methanol gives pure V-demethyl-epipodophyllotoxin-8-D-glucoside with a melting point of 225-227°C, /"«7D<21> = -88.6° (c = 1.05) in methanol. A other modification has melting point 262-26Lt-°C.
EKSEMPEL 7: V- demetyl- epipodofyllotoksin- 3- D- glukosid EXAMPLE 7: V-demethyl-epipodophyllotoxin-3-D-glucoside
2,0 g av det i eksempel 5 erholdte tetra-0-acetyl-V-demetyl-epipodofyllotoksin-8-D-glukosid og 1 g vannfritt sinkacetat oppvarmes i 30 ml abs. metanol i 25 timer under tilbakelop. 2.0 g of the tetra-O-acetyl-V-demethyl-epipodophyllotoxin-8-D-glucoside obtained in example 5 and 1 g of anhydrous zinc acetate are heated in 30 ml of abs. methanol for 25 hours under reflux.
Deretter bringes det dannede hvite bunnfall i losning ved tilsetting av noen ml iseddik og forsiktig oppvarming, losningsmidlet fjernes i vakuum ved 1+0°C og resten opptas i 50 ml klorofornybutanol (Vi). Den organiske fase vaskes to ganger med hver gang 10 ml vann, etter torring over natriumsulfat inndampes i vakuum og resten kromatograferes på silikagel. Isopropylacetat^netanol (9:1), vannmettet, eluerer forst The white precipitate formed is then dissolved by the addition of a few ml of glacial acetic acid and gentle heating, the solvent is removed in vacuo at 1+0°C and the residue is taken up in 50 ml of chloroform butanol (Vi). The organic phase is washed twice with 10 ml of water each time, after drying over sodium sulphate it is evaporated in vacuo and the residue is chromatographed on silica gel. Isopropyl acetate^ethanol (9:1), water saturated, elutes first
upolare andeler, deretter rent V-dernetyl-epipodofyllotoksin-B-D^glukosid. De enkelte fraksjoner underkastes i tynnskiktkromatogram på silikagelplater med stromningsmidlet isopropylaceta"ymetanol (8:1), vannmettet, og glukosidfratejonene forenes og krystalliseres to ganger fra metanol. V-<de>rne tyl-epipodofyllotoksin-B-D-glukosid smelter ved 222-230°C, en annen modifikasjon ved 262-26V°C, Z"d7D<21> = -88° (c = 0,507) i metanol. nonpolar portions, then pure V-dernetyl-epipodophyllotoxin-B-D^glucoside. The individual fractions are submitted to a thin-layer chromatogram on silica gel plates with the eluant isopropylacetaminoethanol (8:1), saturated with water, and the glucoside fraternoids are combined and crystallized twice from methanol. V-<de>rne tyl-epipodophyllotoxin-B-D-glucoside melts at 222-230° C, another modification at 262-26V°C, Z"d7D<21> = -88° (c = 0.507) in methanol.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873727157 DE3727157A1 (en) | 1987-08-14 | 1987-08-14 | NATURAL STONE CLADDING ELEMENT AND METHOD FOR THE PRODUCTION THEREOF |
PCT/EP1988/000694 WO1989001553A1 (en) | 1987-08-14 | 1988-08-01 | Facing element with a natural stone plate and process for manufacturing same |
Publications (4)
Publication Number | Publication Date |
---|---|
NO891520D0 NO891520D0 (en) | 1989-04-13 |
NO891520L NO891520L (en) | 1989-04-13 |
NO170896B true NO170896B (en) | 1992-09-14 |
NO170896C NO170896C (en) | 1992-12-23 |
Family
ID=25858660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO891520A NO170896C (en) | 1987-08-14 | 1989-04-13 | CLOTHING ELEMENT AND PROCEDURE FOR MANUFACTURING SUCH ITEMS |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO170896C (en) |
-
1989
- 1989-04-13 NO NO891520A patent/NO170896C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO170896C (en) | 1992-12-23 |
NO891520D0 (en) | 1989-04-13 |
NO891520L (en) | 1989-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3803124A (en) | Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives | |
Ness et al. | The reaction of 2, 3, 4, 6-tetrabenzoyl-α-D-glucopyranosyl bromide and 2, 3, 4, 6-tetrabenzoyl-α-D-mannopyranosyl bromide with methanol. Certain benzoylated derivatives of D-Glucose and D-Mannose | |
EP0597915B1 (en) | A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide | |
US4369178A (en) | Glucosamine peptide derivatives, their production and use | |
DE2655500A1 (en) | GLUCOSAMINE DERIVATIVES AND A METHOD FOR THE PREPARATION | |
EP0015468B1 (en) | 6-deoxyglucosamine-peptide derivatives, their production and use | |
US3408441A (en) | Epipodophyllotoxin-beta-d-glucosides and derivatives thereof | |
NO173239B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC ACTIVE ETHOPODOPHYLLOTOXINGLUCOSIDACYL DERIVATIVE | |
US2824874A (en) | Reserpic acid and derivatives | |
US5066645A (en) | Epipodophyllotoxin altroside derivatives | |
KR920000646B1 (en) | Fluoro-substituted epipodophyllo-toxin glucosides | |
US3736313A (en) | Erythromycin derivatives | |
NO170896B (en) | CLOTHING ELEMENT AND PROCEDURE FOR MANUFACTURING SUCH ITEMS | |
CN108003027B (en) | 1-O-caffeoylquinic acid, its derivative, preparation method and use thereof | |
CS203193B2 (en) | Method of producing n 1-glucofuranosid-6-yl-n 3-nitrosoureas | |
US3171833A (en) | Method of preparing 1-glucosyl-6-azauracils | |
NO120371B (en) | ||
Jones et al. | 247. Synthesis of some derivatives of D-and L-arabinose | |
US2813871A (en) | O-syringoyl reserpic acid esters | |
NO165984B (en) | STRONGLY ABSORBING OBJECTS. | |
US2728763A (en) | Preparation of benzimidazole glycosides | |
SU330615A1 (en) | ||
US4251529A (en) | Ergot peptide alkaloids | |
NO164794B (en) | Deadlock. | |
US3049551A (en) | Novobiocin intermediate and process therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2002 |